Estrogen receptors and proliferation markers in primary and recurrent breast cancer - Wikidata - wikimedia - TriplyDB

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

http://www.wikidata.org/entity/Q33953032

about

Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor β transcription in breast cancer cells PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development Suppression of estrogen receptor-mediated transcription and cell growth by interaction with TR2 orphan receptor Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer ERbeta in breast cancer--onlooker, passive player, or active protector?Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines Gene expression profiling of the tumor microenvironment during breast cancer progression.Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.Probing the link between oestrogen receptors and oesophageal cancer.Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients.Estrogen receptor-alpha methylation predicts melanoma progression Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer.GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast Expression of estrogen receptor alpha and beta is decreased in hypospadias.ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.Transcription factor decoy (TFD) in breast cancer research and treatment.Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.Breast Tissue Composition and Immunophenotype and Its Relationship with Mammographic Density in Women at High Risk of Breast Cancer.Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer.Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.Estrogen receptor-beta and breast cancer: translating biology into clinical practice Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer.Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action.Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation Hormones and progeny of breast tumor cells.Regulatory function of the P295-T311 motif of the estrogen receptor alpha - does proteasomal degradation of the receptor induce emergence of peptides implicated in estrogenic responses?Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.Tamoxifen Action in ER-Negative Breast Cancer.Comparison of the effects of phenethyl isothiocyanate and sulforaphane on gene expression in breast cancer and normal mammary epithelial cells.Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody.Development and Characterization of Novel Rat Anti-mERβ Sera.Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland.Sex hormone receptor repertoire in breast cancer.Significance of ERβ expression in different molecular subtypes of breast cancer.

P2860

Q21090900-06248DAD-7A7B-4DAD-8726-DFD4F26B911E Q24295182-90040F87-8DF8-4CAF-B717-C34C8CAD534D Q24300794-D54EE82F-0FA4-450B-AE46-5F0590C62166 Q24315496-23E40434-E8B0-4232-9723-69AB01279242 Q24562820-4DAF2EF6-857B-4991-9CAB-488B5B51DA68 Q26773907-74CF7BB0-CE9B-4A00-8FB6-E8306C7DDAC8 Q30438399-8443E495-FA80-4372-BD20-5FE6FDF02100 Q33403066-836F5ED6-76C6-42CF-A1AE-74BB56D76131 Q33404889-BBB0B8C7-8179-4CEF-A010-86205BE1D326 Q33632616-14D82B4F-78AF-48FF-832B-10B67600060F Q33702570-899C2A2C-29A8-4A12-825C-331E14D3F0BA Q33706176-B0C592E8-092B-4596-96DF-83AC22C9A3A0 Q33797076-5913AA9D-33B3-474C-8BAE-5E6AB34F6899 Q33800419-77A75F2A-63B4-4823-B608-006E3137087D Q33882180-E764F20C-6F7A-4528-93DF-D3CC6B1B4BCC Q34254978-0861D00E-2AFA-4E04-AF41-415B6D4F7A14 Q34334131-D6005E4F-AF52-46C0-A1F8-7E0C8541FEAC Q34663257-D75BB62B-F62D-47FD-A9D9-1BD932371960 Q35081110-17D0AEED-A6B6-44EE-86F1-70ECC0F8115A Q35271188-13F840C1-FFDA-4F8C-885E-FAFE8E8EE5B6 Q35558946-7CB8DB39-8229-498C-8F38-B139CBBEEF0E Q35587582-9A8037E7-89F8-475B-BFE4-00A5A392C063 Q35674339-688E79A0-8D57-49FC-919B-695ACE5B7A29 Q35758100-5A17EAC0-561F-4F61-A935-FBBA2BD9614D Q35835151-2E99515E-AD08-4953-A148-9E2EE61F7598 Q35931634-B756DD24-07A9-4665-B371-5ACB9ACEA117 Q35973424-EAFE415C-1B18-4B36-8629-2C49B49AAE5A Q35993074-62D11201-6DF0-4AA7-9608-A62C621990C5 Q36323480-4F40418C-7F6A-4749-B08C-89EEA01486A2 Q36441837-F8D56303-1A6C-4DE8-B311-962CA9D0F24F Q36477872-1049238A-4EA3-4489-A47E-C90E50C73AEF Q36579764-C72DF286-0E2F-47A7-BABD-DA11D67240C3 Q36612259-A8430836-1432-44C9-A0A7-100D60991776 Q36688302-8605DF10-7248-4B79-BD49-96E08DE30FE1 Q36973808-9ED2716D-5594-4D6A-9D1D-595AD458144A Q37049590-15149A4D-ED9D-4F67-A51E-C1BDE7367982 Q37057450-4FD0A961-98F9-401B-8085-E1632F2D3537 Q37094546-993C8F75-7D11-41AB-B6B5-D48150A04C15 Q37353645-A34506BB-9197-4420-B71E-2208B20CAA44 Q37548570-620E4708-621C-437B-9CA6-5ADE3E5BEDB6

P2860

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

http://www.wikidata.org/entity/Q33953032

description

2001 nî lūn-bûn

@nan

2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

@ast

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

@en

type

label

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

@ast

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

@en

prefLabel

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

@ast

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

@en

P1433

Q33953032-8B4740AB-5FD1-42C5-BFA4-360CE09D3D04

P1476

Q33953032-4863FB57-E6BF-4D61-B763-24681BF77291

P2093

Q33953032-11DC3FE7-0711-4CC5-ABF7-FB5D1D2C4019

Q33953032-3BDC5B75-6EDE-4571-B985-2555C8C215ED

Q33953032-437F76AC-CAF7-4705-B6CB-2217FA338D3F

Q33953032-52E49DB1-DEFD-462E-BDF1-46BF66FAB9FD

Q33953032-7ECE4ABE-8035-4DBC-B727-522554457E2A

Q33953032-8B9B62F2-37FC-43BB-B87D-35B1052A3E7D

Q33953032-A3A0ADC3-7497-4338-B27B-C6E0A547B99A

Q33953032-D3DEE194-CDE6-41FB-A7F8-D22DD49948E7

Q33953032-F01870ED-7129-48B1-88C7-80BC4F36B95E

Q33953032-F3062E07-353B-4EAD-9817-8A61261D725A

P2860

Q33953032-036A0841-8189-4235-BDCA-1F880392FC94

Q33953032-10D91F16-3B53-49DE-959F-33F7546C145D

Q33953032-1FDF85DC-8FFD-40C4-A430-8E6D3A73D870

Q33953032-2CC8FFA3-74FF-4A48-BEFB-6C8A7FE47389

Q33953032-30025498-E287-438D-B77D-77AF4A260322

Q33953032-3639EFBD-96C8-477E-B637-B753765C3ACB

Q33953032-37842E32-B265-439F-9BF8-52FD92675071

Q33953032-3C311B62-4032-417B-AD27-5AF86305D6FE

Q33953032-4033AB4F-D7FB-4FB0-8189-217A15881535

Q33953032-443119B4-0D09-4497-A35D-5B210491E8D2

P304

Q33953032-C807F727-0D21-4206-AA15-9F6518FA2B0A

P31

Q33953032-9E2C0677-5A9C-4A86-A388-F0452F1959D2

P356

Q33953032-81C7D134-8B10-4C45-A406-AB18481F32F2

P407

Q33953032-0152744A-FA60-4661-A7F8-BC71251E2F86

P433

Q33953032-F34753DC-2D07-4265-8FED-ADA09D954AE4

P478

Q33953032-0D87D716-929B-4F8C-B538-472E1AC4BFEB

P577

Q33953032-0B9ABAF3-CF96-4AD1-9E5E-F2C23C43E192

P5875

Q33953032-55D4890F-7A2E-41E5-8631-343478C59247

P698

Q33953032-A6615ACE-3A6C-4032-A90E-7CD218B38E88

P932

Q33953032-687CA594-FC25-4559-BBBC-7C5A3476996B

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

@en

P2093

Cheng G

http://www.w3.org/2001/XMLSchema#string

Coombes RC

http://www.w3.org/2001/XMLSchema#string

Gustafsson JA

http://www.w3.org/2001/XMLSchema#string

Jensen EV

http://www.w3.org/2001/XMLSchema#string

Mäkelä S

http://www.w3.org/2001/XMLSchema#string

Palmieri C

http://www.w3.org/2001/XMLSchema#string

Saji S

http://www.w3.org/2001/XMLSchema#string

Van Noorden S

http://www.w3.org/2001/XMLSchema#string

Wahlström T

http://www.w3.org/2001/XMLSchema#string

Warner M

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of a novel receptor expressed in rat prostate and ovary

The pharmacology and clinical uses of tamoxifen

Basic guide to the mechanisms of antiestrogen action

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

The influence of maternal diet on breast cancer risk among female offspring.

The estrogen receptor family.

Postmenopausal hormone use for cardioprotection: what we know and what we must learn.

Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer.

P304

15197-15202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.211556298

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2001-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235616066

http://www.w3.org/2001/XMLSchema#string

P698

11734621

http://www.w3.org/2001/XMLSchema#string

P932

65006

http://www.w3.org/2001/XMLSchema#string